Second-trimester amniotic fluid or maternal serum interleukin-10 levels and small for gestational age neonates

Obstetrics and Gynecology

Volumn 88, Issue 1, 1996, Pages 24-28

  Spong, Catherine Y ^a   Sherer, David M ^a   Ghidini, Alessandro ^a   Jenkins, Chuka B ^a   Seydel, Frank D ^a   Eglinton, Gary S ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GESTATIONAL AGE; HUMAN; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT;

EID: 0029978930     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00110-X     Document Type: Article

References (16)

1. Williams RL, Creasy RK, Cunningham GC, Hawes WE, Norris FD, Tashiro M. Fetal growth and perinatal viability in California. Obstet Gynecol 1982;5:624-32.
2. Lin CC, Su SJ, River LP. Comparison of associated high-risk factors and perinatal outcome between symmetric and asymmetric fetal intrauterine growth retardation. Am J Obstet Gynecol 1991;164: 1535-42.
3. Visser GHA, Huisman A, Saathof PWF, Sinnige HAM. Early fetal growth retardation: Obstetric background and recurrence rate. Obstet Gynecol 1986;67:40-3.
4. Labarrere C, Alonso J, Manni J, Domenichini E, Althabe O. Immunohistochemical findings in acute atherosis associated with intrauterine growth retardation. Am J Reprod Immunol Microbiol 1985;7:149-55.
5. Sheppard BL, Bonner J. An ultrastructure study of uteroplacental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol 1981;188:695-705.
6. Trudinger BJ, Giles WB, Cook CM. Flow velocity waveforms in the maternal uteroplacental and fetal umbilical placental circulations. Am J Obstet Gynecol 1985;152:155-63.
7. Brosens I, Dixon HG, Robertson WB. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol 1977;84:656-63.
8. DeWoIf F, Brosens I, Renaer M. Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension. Br J Obstet Gynaecol 1980;87:678-85.
9. Mosman TR Interleukin-10. In: Thomson AW, ed. The cytokine handbook. San Diego, California: Academic Press, 1994:223-37.
10. Greig PC, Herbert WNP, Robinette BS, Teot LA. Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infection. Am J Obstet Gynecol 1995;173:1223-7.
11. Abrams JS, Roncarolo MG, Yssel H, Andersen U, Gleich GJ, Silver JE. Strategies of anti-cytokine monoclonal antibody development: Immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 1992;127:5-24.
12. Heyborne KD, McGregor JA, Henry G. Interleukin-10 in AF at midtrimester: Immune activation and suppression in relation to fetal growth. Am J Obstet Gynecol 1994;171:55-9.
13. Wennergren M, Wennergren G, Vilbergsson G. Obstetric characteristics and neonatal performance in a four-year small for gestational age population. Obstet Gynecol 1988;72:615-20.
14. Ott WJ. Intrauterine growth retardation and preterm delivery. Am J Obstet Gynecol 1993;168:1710-7.
15. Hediger ML, Scholl TO, Schall JI, Miller LW, Fischer RL. Fetal growth and the etiology of preterm delivery. Obstet Gynecol 1995;85:175-81.
16. Beyer WH. Number of observations for t test of difference between two means. In: CRC basic statistical tables. 1971:88-9.